Hospital Pharmacy - November 2017 - 679

726869
research-article2017

HPXXXX10.1177/0018578717726869Hospital PharmacyGhamrawi et al.

Article

Evaluation of Antimicrobial
Stewardship-Related Alerts Using a
Clinical Decision Support System

Hospital Pharmacy
2017, Vol. 52(10) 679-684
© The Author(s) 2017
Reprints and permissions:
sagepub.com/journalsPermissions.nav
https://doi.org/10.1177/0018578717726869
DOI: 10.1177/0018578717726869
journals.sagepub.com/home/hpx

Riane J. Ghamrawi1,2, Alexander Kantorovich3,4, Seth R. Bauer5,
Andrea M. Pallotta5, Jennifer K. Sekeres5, Steven M. Gordon5,
and Elizabeth A. Neuner5

Abstract
Background: Information technology, including clinical decision support systems (CDSS), have an increasingly important
and growing role in identifying opportunities for antimicrobial stewardship-related interventions. Objective: The aim of
this study was to describe and compare types and outcomes of CDSS-built antimicrobial stewardship alerts. Methods:
Fifteen alerts were evaluated in the initial antimicrobial stewardship program (ASP) review. Preimplementation, alerts were
reviewed retrospectively. Postimplementation, alerts were reviewed in real-time. Data collection included total number
of actionable alerts, recommendation acceptance rates, and time spent on each alert. Time to de-escalation to narrower
spectrum agents was collected. Results: In total, 749 alerts were evaluated. Overall, 306 (41%) alerts were actionable (173
preimplementation, 133 postimplementation). Rates of actionable alerts were similar for custom-built and prebuilt alert types
(39% [53 of 135] vs 41% [253 of 614], P = .68]. In the postimplementation group, an intervention was attempted in 97%
of actionable alerts and 70% of interventions were accepted. The median time spent per alert was 7 minutes (interquartile
range [IQR], 5-13 minutes; 15 [12-17] minutes for actionable alerts vs 6 [5-7] minutes for nonactionable alerts, P < .001). In
cases where the antimicrobial was eventually de-escalated, the median time to de-escalation was 28.8 hours (95% confidence
interval [CI], 10.0-69.1 hours) preimplementation vs 4.7 hours (95% CI, 2.4-22.1 hours) postimplementation, P < .001.
Conclusions: CDSS have played an important role in ASPs to help identify opportunities to optimize antimicrobial use
through prebuilt and custom-built alerts. As ASP roles continue to expand, focusing time on customizing institution specific
alerts will be of vital importance to help redistribute time needed to manage other ASP tasks and opportunities.
Keywords
antimicrobial stewardship, clinical decision support systems, infectious diseases

Introduction
Antimicrobial resistance threatens the treatment of once
manageable infections with over 2 million illnesses and
23 000 deaths annually attributed to organisms resistant to
currently available antimicrobials in the United States.1-3
National organizations, including Infectious Diseases
Society of America, have advocated and provided guidance
for establishing antimicrobial stewardship programs (ASPs)
to help alleviate the increasing risk of emerging resistant
microorganisms and to optimize the use of currently available antimicrobials. One of the core interventions of ASPs to
assist with reducing inappropriate use of antimicrobials
includes prospectively auditing and intervening on antimicrobial use, and then providing feedback and recommendations to medical team members.1
Health care information technology has had an increasingly growing and important role in the identification of

ASP-related tasks and interventions. Electronic health
records (EHR) and clinical decision support systems (CDSS),
such as TheraDocTM (Salt Lake City, Utah), provide realtime alerts updated when new microbial culture results
become available or antimicrobial changes occur. These
1

University of Cincinnati- West Chester Hospital, OH, USA
University of Cincinnati- Daniel Drake Center for Post-Acute Care,
OH, USA
3
Chicago State University, IL, USA
4
Advocate Christ Medical Center, IL USA
5
Cleveland Clinic, OH, USA
2

Corresponding Author:
Riane J. Ghamrawi, Pharmacy Clinical Specialist - Antimicrobial
Stewardship/Infectious Diseases, University of Cincinnati- West Chester
Hospital, 7700 University Drive, West Chester, Ohio 45069, USA.
University of Cincinnati - Daniel Drake Center for Post-Acute Care,
151 W Gallbraith Road, Cincinnati, OH 45216, USA.
Email: riane.ghamrawi@uchealth.com


https://us.sagepub.com/en-us/journals-permissions http://journals.sagepub.com/home/hpx

Table of Contents for the Digital Edition of Hospital Pharmacy - November 2017

AKD—The Time Between AKI and CKD: What Is the Role of the Pharmacist?
Letter to the Editor
Antithrombotic Therapy Post Endovascular Stenting for Superior Vena Cava Syndrome
Pharmaceutical Pipeline Update
Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Formulary Drug Reviews
Etelcalcetide
Treatment of Hypertriglyceridemia-Induced Acute Pancreatitis With Insulin, Heparin, and Gemfibrozil: A Case Series
Evaluation of Antimicrobial Stewardship–Related Alerts Using a Clinical Decision Support System
Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution
Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence
Underutilization of Aldosterone Antagonists in Heart Failure
Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags
Development of a Local Health-System Pharmacy Resident Society
Challenges and Solutions to New Manager Onboarding
Hospital Pharmacy - November 2017 - 649
Hospital Pharmacy - November 2017 - 650
Hospital Pharmacy - November 2017 - 651
Hospital Pharmacy - November 2017 - 652
Hospital Pharmacy - November 2017 - 653
Hospital Pharmacy - November 2017 - 654
Hospital Pharmacy - November 2017 - 655
Hospital Pharmacy - November 2017 - 656
Hospital Pharmacy - November 2017 - 657
Hospital Pharmacy - November 2017 - 658
Hospital Pharmacy - November 2017 - 659
Hospital Pharmacy - November 2017 - 660
Hospital Pharmacy - November 2017 - AKD—The Time Between AKI and CKD: What Is the Role of the Pharmacist?
Hospital Pharmacy - November 2017 - 662
Hospital Pharmacy - November 2017 - Letter to the Editor
Hospital Pharmacy - November 2017 - Pharmaceutical Pipeline Update
Hospital Pharmacy - November 2017 - Janus Kinase Inhibitors for the Treatment of Rheumatoid Arthritis
Hospital Pharmacy - November 2017 - Formulary Drug Reviews
Hospital Pharmacy - November 2017 - Etelcalcetide
Hospital Pharmacy - November 2017 - 668
Hospital Pharmacy - November 2017 - 669
Hospital Pharmacy - November 2017 - 670
Hospital Pharmacy - November 2017 - 671
Hospital Pharmacy - November 2017 - 672
Hospital Pharmacy - November 2017 - Treatment of Hypertriglyceridemia-Induced Acute Pancreatitis With Insulin, Heparin, and Gemfibrozil: A Case Series
Hospital Pharmacy - November 2017 - 674
Hospital Pharmacy - November 2017 - 675
Hospital Pharmacy - November 2017 - 676
Hospital Pharmacy - November 2017 - Evaluation of Antimicrobial Stewardship–Related Alerts Using a Clinical Decision Support System
Hospital Pharmacy - November 2017 - 678
Hospital Pharmacy - November 2017 - 679
Hospital Pharmacy - November 2017 - 680
Hospital Pharmacy - November 2017 - 681
Hospital Pharmacy - November 2017 - 682
Hospital Pharmacy - November 2017 - Compatibility, Stability, and Efficacy of Vancomycin Combined With Gentamicin or Ethanol in Sodium Citrate as a Catheter Lock Solution
Hospital Pharmacy - November 2017 - 684
Hospital Pharmacy - November 2017 - 685
Hospital Pharmacy - November 2017 - 686
Hospital Pharmacy - November 2017 - 687
Hospital Pharmacy - November 2017 - 688
Hospital Pharmacy - November 2017 - Development of Institutional Guidelines for Management of Gram-Negative Bloodstream Infections: Incorporating Local Evidence
Hospital Pharmacy - November 2017 - 690
Hospital Pharmacy - November 2017 - 691
Hospital Pharmacy - November 2017 - 692
Hospital Pharmacy - November 2017 - 693
Hospital Pharmacy - November 2017 - 694
Hospital Pharmacy - November 2017 - 695
Hospital Pharmacy - November 2017 - Underutilization of Aldosterone Antagonists in Heart Failure
Hospital Pharmacy - November 2017 - 697
Hospital Pharmacy - November 2017 - 698
Hospital Pharmacy - November 2017 - 699
Hospital Pharmacy - November 2017 - 700
Hospital Pharmacy - November 2017 - 701
Hospital Pharmacy - November 2017 - Stability of Procainamide Injection in Clear Glass Vials and Polyvinyl Chloride Bags
Hospital Pharmacy - November 2017 - 703
Hospital Pharmacy - November 2017 - 704
Hospital Pharmacy - November 2017 - 705
Hospital Pharmacy - November 2017 - 706
Hospital Pharmacy - November 2017 - Development of a Local Health-System Pharmacy Resident Society
Hospital Pharmacy - November 2017 - 708
Hospital Pharmacy - November 2017 - 709
Hospital Pharmacy - November 2017 - Challenges and Solutions to New Manager Onboarding
Hospital Pharmacy - November 2017 - 711
Hospital Pharmacy - November 2017 - 712
Hospital Pharmacy - November 2017 - 713
Hospital Pharmacy - November 2017 - 714
Hospital Pharmacy - November 2017 - 715
Hospital Pharmacy - November 2017 - 716
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2020
https://www.nxtbook.com/nxtbooks/sage/psychologicalscience_demo
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2020
https://www.nxtbook.com/nxtbooks/sage/fai_202009
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_august2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2020
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2019
https://www.nxtbook.com/nxtbooks/sage/fai_201909
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_july2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2019
https://www.nxtbook.com/nxtbooks/sage/canadianpharmacistsjournal_05062019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2019
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201903
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2019
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2018
https://www.nxtbook.com/nxtbooks/sage/tec_20180810
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2018
https://www.nxtbook.com/nxtbooks/sage/fai_201807
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_april2018
https://www.nxtbook.com/nxtbooks/sage/sri_supplement_201803
https://www.nxtbook.com/nxtbooks/sage/slas_discovery_201712
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_february2018
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_december2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_november2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_october2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_september2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_julyaugust2017
https://www.nxtbook.com/nxtbooks/sage/fai_supplement_201709
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_june2017
https://www.nxtbook.com/nxtbooks/sage/hospitalpharmacy_may2017
https://www.nxtbook.com/nxtbooks/sage/fai_201706
https://www.nxtbook.com/nxtbooks/sage/fai_201607
https://www.nxtbookmedia.com